241 related articles for article (PubMed ID: 36706185)
1. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression.
Liu C; Zhang M; Yan X; Ni Y; Gong Y; Wang C; Zhang X; Wan L; Yang H; Ge C; Li Y; Zou W; Huang R; Li X; Sun B; Liu B; Yue J; Yu J
Sci Adv; 2023 Jan; 9(4):eadd8977. PubMed ID: 36706185
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
5. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
6. Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma.
Xiong G; Shan J; Chong Q; Cui Y
Aging (Albany NY); 2024 Apr; 16(8):6898-6920. PubMed ID: 38709170
[TBL] [Abstract][Full Text] [Related]
7. DGUOK-AS1 promotes cervical squamous cell carcinoma progression by suppressing miR-499a-5p that targets SPRR1B in vitro.
Song Y; Pan H; Yang L; Fan Y; Zhang H; Pan M; Zhang Y
Biochem Biophys Res Commun; 2021 Dec; 585():177-184. PubMed ID: 34808501
[TBL] [Abstract][Full Text] [Related]
8. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0072008 regulates cell proliferation, migration, and invasion in cervical squamous cell carcinoma via miR-1305/helicase, lymphoid specific (HELLS) axis.
He C; Liu L
Bioengineered; 2022 Apr; 13(4):8311-8322. PubMed ID: 35311456
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma.
Dong Z; Chang X; Xie L; Wang Y; Hou Y
Bioengineered; 2022 Mar; 13(3):6100-6112. PubMed ID: 35192432
[TBL] [Abstract][Full Text] [Related]
11. ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.
Zhen L; Pan W
Clin Exp Pharmacol Physiol; 2023 May; 50(5):380-392. PubMed ID: 36705046
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
[No Abstract] [Full Text] [Related]
13. BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma.
Song J; Xu F; An L; Yin Y; Liu J; Chai J; Yang Y; Li M; Jia Q; Wang Z
Pathol Res Pract; 2023 Jul; 247():154577. PubMed ID: 37257243
[TBL] [Abstract][Full Text] [Related]
14. Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes.
Liu M; Wei D; Nie Q; Peng L; He L; Cui Y; Ye Y
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):663-671. PubMed ID: 35779918
[TBL] [Abstract][Full Text] [Related]
15. ERBB3 methylation and immune infiltration in tumor microenvironment of cervical cancer.
Yang X; Chen Y; Li M; Zhu W
Sci Rep; 2022 May; 12(1):8112. PubMed ID: 35581263
[TBL] [Abstract][Full Text] [Related]
16. CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma.
Zhang J; Dong D; Wei Q; Ren L
BMC Cancer; 2022 Oct; 22(1):1052. PubMed ID: 36207693
[TBL] [Abstract][Full Text] [Related]
17. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC.
Song J; Ye A; Jiang E; Yin X; Chen Z; Bai G; Zhou Y; Liu J
J Cell Biochem; 2018 Aug; 119(8):6665-6673. PubMed ID: 29741786
[TBL] [Abstract][Full Text] [Related]
18. Metabolism-associated molecular classification of cervical cancer.
Zhao M; Zhang X; Huan Q; Dong M
BMC Womens Health; 2023 Oct; 23(1):555. PubMed ID: 37884919
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
[TBL] [Abstract][Full Text] [Related]
20. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
